These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11786104

  • 1. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.
    Torres A, Domínguez-Gil B, Carreño A, Hernández E, Morales E, Segura J, González E, Praga M.
    Kidney Int; 2002 Jan; 61(1):219-27. PubMed ID: 11786104
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 Aug; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
    Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL, North America Nephrotic Syndrome Study Group.
    Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 6. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 7. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M, Grcevska L, Dzikova S.
    Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
    [Abstract] [Full Text] [Related]

  • 8. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.
    Yang S, Xie L, Xue W, Yin A, Lu W.
    Nephrology (Carlton); 2013 Sep; 18(9):615-22. PubMed ID: 23889815
    [Abstract] [Full Text] [Related]

  • 9. [Clinical outcome assessment of membranous nephropathy].
    Kumagai T, Shimizu H, Nishi T, Mise N, Tagawa H, Sugimoto T.
    Nihon Jinzo Gakkai Shi; 2005 Sep; 47(8):870-5. PubMed ID: 16408431
    [Abstract] [Full Text] [Related]

  • 10. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 11. Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?
    Ahuja M, Goumenos D, Shortland JR, Gerakis A, Brown CB.
    Am J Kidney Dis; 1999 Sep; 34(3):521-9. PubMed ID: 10469864
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 13. Idiopathic Membranous Nephropathy and Treatment Related Complications.
    Uncanin S, Dzemidzic J, Serdarevic N, Muslimovic A, Haskovic D.
    Med Arch; 2020 Jun 05; 74(3):228-232. PubMed ID: 32801441
    [Abstract] [Full Text] [Related]

  • 14. The therapy of idiopathic membranous glomerulonephritis.
    Glassock RJ.
    Semin Nephrol; 1991 Mar 05; 11(2):138-47. PubMed ID: 2034923
    [Abstract] [Full Text] [Related]

  • 15. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan 05; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 16. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
    Polanco N, Gutiérrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D, Praga M, Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN).
    Nephrol Dial Transplant; 2012 Jan 05; 27(1):231-4. PubMed ID: 21624942
    [Abstract] [Full Text] [Related]

  • 17. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.
    J Am Soc Nephrol; 1998 Mar 05; 9(3):444-50. PubMed ID: 9513907
    [Abstract] [Full Text] [Related]

  • 18. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
    Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
    Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
    Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S.
    N Engl J Med; 1989 Jan 26; 320(4):210-5. PubMed ID: 2643046
    [Abstract] [Full Text] [Related]

  • 20. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb 26; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.